Page 7 - Project Twenty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited ("Astral Health"). Astral Health is fully owned by LYPHE Group, which is part of Drug Science's Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod and a line of medicinal cannabis formulations in pods for the UK market. Through this new framework agreement, it is intended that Kanabo's VapePod medicinal cannabi...

A look at some of the major movers in London on Tuesday

Share this article Share this article LONDON, Feb. 17, 2021 /PRNewswire/ -- LYPHE Group, U.K.'s leading medical cannabis provider, with more than 60% of the British patient market, and Canadian independent EU GMP manufacturer, Northern Green have entered into a supply partnership that will see a range of indoor grown flowers enter the market under the brand name of NOIDECS. The flowers are now available in the private market and through NOIDECS' inclusion on the formulary of Europe's largest patient real world data registry, Drug Science's Project Twenty21. Under the agreement, NOIDECS is al...